Recommended Item: Atezolizumab (atezo) vs best supportive care (BSC) in stage II-IIIA NSCLC with high PD-L1 expression: Sub-analysis from the pivotal phase III IMpower010 study

To recommend this item to someone, complete the form below. Fields marked with a '*' are required.